« Back to Record
Citation APA

Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., Paesmans, M., Ameye, L., Shivaprakash, M., Ullmann, A., Maertens, J., & Infectious Disease Group of the EORTC, (2009). An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. Journal of antimicrobial chemotherapy, 64(6), 1274-1281. doi:10.1093/jac/dkp355


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/119833

Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., Paesmans, M., Ameye, L., Shivaprakash, M., Ullmann, A., Maertens, J., & Infectious Disease Group of the EORTC, (2009). An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. Journal of antimicrobial chemotherapy, 64(6), 1274-1281. doi:10.1093/jac/dkp355